The lived experience of severe pain, understandably, can lead to a process of catastrophizing, which is a cognitive distortion where patients assume the worst possible outcome in any situation where ...

The new FDA-approved pain drug is suzetrigine, with the brand name Journavx. Suzetrigine is designed to alleviate moderate to severe pain and, it’s hoped, can be an option that will lead to fewer ...

Music has the best chance of providing pain relief when it is played at our natural rhythm, a McGill University research team ...

The U.S. Food and Drug Administration (FDA) approved Thursday a new type of prescription pain medication for moderate to ...